Nektaria Dimopoulos
Publications by Year
Research Areas
Immunotherapy and Immune Responses, T-cell and B-cell Immunology, Immune Cell Function and Interaction, vaccines and immunoinformatics approaches, Melanoma and MAPK Pathways
Most-Cited Works
- → Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans(2004)438 cited
- → MEK Inhibition, Alone or in Combination with BRAF Inhibition, Affects Multiple Functions of Isolated Normal Human Lymphocytes and Dendritic Cells(2014)138 cited
- The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand.(2004)
- → Regulatory T-Cell–Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma(2009)118 cited
- → Melan-A–specific Cytotoxic T Cells Are Associated with Tumor Regression and Autoimmunity Following Treatment with Anti-CTLA-4(2009)97 cited
- → Immunodominant CD4 + responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant(2004)90 cited
- → Cross‐priming of CD8+ T cells by viral and tumor antigens is a robust phenomenon(2003)83 cited
- → Reversal in the Immunodominance Hierarchy in Secondary CD8+ T Cell Responses to Influenza A Virus: Roles for Cross-Presentation and Lysis-Independent Immunodomination(2004)76 cited
- → Blood Dendritic Cells Generated With Flt3 Ligand and CD40 Ligand Prime CD8+ T Cells Efficiently in Cancer Patients(2006)71 cited
- → Structural Determinants of Aldosterone Binding Selectivity in the Mineralocorticoid Receptor(1999)67 cited